Former Lawyer Went From $50K To $5.3M Trading Options

From Investing Daily | Ad

Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M

I'll show you how I did it here.

INCY Insider Trading (Incyte)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.80%

Insider Buying (Last 12 Months): $153,065,544.39

Insider Selling (Last 12 Months): $5,898,964.82

Incyte Insider Trading History Chart

Incyte Share Price & Price History

^$77.67

▲ +1.7 (2.24%)

As of 07/1/2022 01:00 AM ET

Days: 30 | 90 | 365

Being A Successful Trader Just Got Easier…

From Tradewins | Ad

From 10x Trading Champion Chuck Hughes comes the e-book helping thousands to survive the bear market, “Options trading Made Easy”!

Already full of tools and strategies for success, each copy now comes with a daily Trade of the Day, straight from Chuck to you!

Download your copy now!

>>>

Incyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2022	Barry P Flannelly	EVP	Sell	43,993	$83.49	$3,672,975.57	65,163
3/10/2022	Bros. Advisors Lp Baker	Director	Buy	218,563	$73.13	$15,983,512.19
3/8/2022	Bros. Advisors Lp Baker	Director	Buy	100,000	$70.67	$7,067,000.00
2/22/2022	Bros. Advisors Lp Baker	Director	Buy	99,800	$68.07	$6,793,386.00
2/17/2022	Bros. Advisors Lp Baker	Director	Buy	292,972	$67.74	$19,845,923.28
1/31/2022	Jonathan Elliott Dickinson	EVP	Sell	7,375	$74.19	$547,151.25
1/7/2022	Paula J. Swain	EVP	Sell	10,870	$73.31	$796,879.70
12/23/2021	Wendy L. Dixon	Director	Sell	20,000	$22.05	$441,000.00
12/17/2021	Bros. Advisors Lp Baker	Director	Buy	1,075,872	$72.80	$78,323,481.60
12/15/2021	Bros. Advisors Lp Baker	Director	Buy	350,332	$71.51	$25,052,241.32
10/1/2021	Dashyant Dhanak	EVP	Sell	389	$68.67	$26,712.63
9/1/2021	Dashyant Dhanak	EVP	Sell	388	$76.71	$29,763.48
7/29/2021	Vijay K. Iyengar	EVP	Sell	4,911	$78.29	$384,482.19
6/29/2021	Wenquing Yao	EVP	Sell	27,194	$85.37	$2,321,551.78
4/1/2021	Dashyant Dhanak	EVP	Sell	396	$81.57	$32,301.72
3/29/2021	Michael James Morrissey	EVP	Sell	20,000	$81.08	$1,621,600.00
2/23/2021	Herve Hoppenot	President	Buy	12,925	$77.37	$1,000,007.25
1/25/2021	Wenquing Yao	EVP	Sell	21,545	$100.00	$2,154,500.00	145,343
10/9/2020	Maria E. Pasquale	EVP	Sell	1,423	$95.00	$135,185.00	29,754
9/10/2020	Maria E. Pasquale	EVP	Sell	2,193	$90.83	$199,190.19	30,397
9/8/2020	Dashyant Dhanak	EVP	Sell	961	$88.94	$85,471.34	28,971
7/16/2020	Steven H. Stein	EVP	Sell	766	$103.83	$79,533.78	96,234
7/8/2020	Steven H. Stein	EVP	Sell	610	$108.56	$66,221.60	104,131
7/7/2020	Herve Hoppenot	CEO	Sell	89,771	$110.00	$9,874,810.00	279,662
7/6/2020	Wenquing Yao	EVP	Sell	16,553	$107.32	$1,776,467.96	158,849
6/26/2020	Herve Hoppenot	CEO	Sell	124,148	$102.91	$12,776,070.68	245,250
6/23/2020	Paul Trower	Insider	Sell	6,943	$110.00	$763,730.00	28,677
6/22/2020	Jonathan Elliott Dickinson	EVP	Sell	9,000	$105.31	$947,790.00	36,461
6/19/2020	Maria E. Pasquale	EVP	Sell	1,423	$100.00	$142,300.00	25,084
5/28/2020	Bros. Advisors Lp Baker	Director	Buy	2	$102.55	$205.10
5/6/2020	Dashyant Dhanak	EVP	Sell	961	$96.84	$93,063.24	20,948
4/17/2020	Paul Trower	Insider	Sell	1,143	$100.00	$114,300.00	22,467
4/16/2020	Maria E. Pasquale	EVP	Sell	9,488	$95.00	$901,360.00	32,837
4/14/2020	Maria E. Pasquale	EVP	Sell	17,827	$90.00	$1,604,430.00	23,864
4/6/2020	Maria E. Pasquale	EVP	Sell	1,842	$85.00	$156,570.00	23,831
3/31/2020	Paula J. Swain	EVP	Sell	2,329	$71.44	$166,383.76	50,132
2/19/2020	Paula J. Swain	EVP	Sell	2,500	$80.00	$200,000.00	50,993
1/15/2020	Paula J. Swain	EVP	Sell	2,500	$81.12	$202,800.00	44,112
12/16/2019	Paula J. Swain	EVP	Sell	2,500	$91.61	$229,025.00	44,112
12/2/2019	Wenquing Yao	EVP	Sell	16,835	$95.00	$1,599,325.00	98,473
11/29/2019	Wenquing Yao	EVP	Sell	3,165	$95.00	$300,675.00	98,473
11/25/2019	Barry P Flannelly	EVP	Sell	2,142	$90.00	$192,780.00	17,401
11/25/2019	Paul Trower	Insider	Sell	15,000	$93.76	$1,406,400.00
11/15/2019	Paula J. Swain	EVP	Sell	2,500	$86.46	$216,150.00	44,112
11/8/2019	Wendy L. Dixon	Director	Sell	41,218	$83.87	$3,456,953.66	22,916
11/6/2019	Wendy L. Dixon	Director	Sell	10,576	$84.16	$890,076.16	22,916
11/1/2019	Paul Trower	Insider	Sell	8,500	$85.00	$722,500.00	25,806
11/1/2019	Wenquing Yao	EVP	Sell	7,960	$85.00	$676,600.00	103,268
10/29/2019	Paul Trower	Insider	Sell	16,500	$80.45	$1,327,425.00	23,907
10/29/2019	Wenquing Yao	EVP	Sell	2,040	$85.00	$173,400.00	47,348
10/22/2019	Paula J. Swain	EVP	Sell	2,500	$80.00	$200,000.00	44,112
9/18/2019	Paula J. Swain	EVP	Sell	2,500	$80.00	$200,000.00	44,112
8/15/2019	Paula J. Swain	EVP	Sell	2,500	$80.96	$202,400.00	44,112
8/6/2019	Paul A Friedman	Director	Sell	100,000	$82.69	$8,269,000.00	277,597
8/2/2019	Jean Jacques Bienaime	Director	Sell	1,724	$85.07	$146,660.68	277,597
7/17/2019	Barry P. Flannelly	EVP	Sell	959	$79.91	$76,633.69
7/15/2019	Paula J. Swain	EVP	Sell	2,500	$80.00	$200,000.00	44,751

Being A Successful Trader Just Got Easier…

From Tradewins | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Incyte (NASDAQ:INCY)

92.78% of Incyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Incyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/30/2022	Amalgamated Bank	49,046	$3.90M	0.0%	+2.8%	0.022%
6/7/2022	Teachers Retirement System of The State of Kentucky	329,729	$26.19M	0.3%	+8.5%	0.149%
6/7/2022	Bank of America Corp DE	367,562	$29.19M	0.0%	-23.6%	0.166%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	48,566	$3.86M	0.0%	+31.7%	0.022%
5/20/2022	International Biotechnology Trust PLC	238,000	$2.58M	0.6%	-16.5%	0.107%
5/20/2022	The Manufacturers Life Insurance Company	1,349,741	$107.22M	0.1%	+7.3%	0.609%
5/20/2022	Toroso Investments LLC	11,938	$0.95M	0.0%	+52.1%	0.005%
5/19/2022	Capital International Sarl	14,544	$1.16M	0.1%	-55.3%	0.007%
5/19/2022	Capital International Ltd. CA	25,750	$2.05M	0.1%	-59.1%	0.012%
5/19/2022	Capital Group International Inc. CA	33,961	$2.70M	0.0%	-69.9%	0.015%
5/19/2022	Capital International Investors	1,397,265	$110.97M	0.0%	-65.6%	0.631%
5/19/2022	Capital Group Private Client Services Inc.	5,576	$0.44M	0.0%	N/A	0.003%
5/18/2022	BNP Paribas Arbitrage SA	157,440	$12.50M	0.0%	+37.9%	0.071%
5/18/2022	Gabelli Funds LLC	16,500	$1.31M	0.0%	+1.2%	0.007%
5/17/2022	Worldquant Millennium Advisors LLC	85,772	$6.81M	0.2%	-70.5%	0.039%
5/17/2022	Wealthfront Advisers LLC	17,980	$1.43M	0.0%	N/A	0.008%
5/17/2022	Weiss Multi Strategy Advisers LLC	25,591	$2.03M	0.0%	-1.7%	0.012%
5/17/2022	Advisors Asset Management Inc.	16,607	$1.32M	0.0%	-22.7%	0.007%
5/17/2022	KB Financial Partners LLC	4,732	$0.38M	0.1%	+11.5%	0.002%
5/17/2022	MidWestOne Financial Group Inc.	17,072	$1.36M	0.3%	-13.5%	0.008%
5/17/2022	Meiji Yasuda Asset Management Co Ltd.	20,023	$1.59M	0.1%	-5.0%	0.009%
5/17/2022	Meiji Yasuda Life Insurance Co	5,917	$0.47M	0.0%	+4.8%	0.003%
5/17/2022	SkyView Investment Advisors LLC	5,052	$0.40M	0.1%	-5.7%	0.002%
5/17/2022	Polar Capital Holdings Plc	1,012,386	$80.40M	0.4%	+100.3%	0.457%
5/17/2022	Royal Bank of Canada	7,682,752	$610.16M	0.2%	+117.4%	3.468%
5/17/2022	Eaton Vance Management	198,514	$15.77M	0.0%	+40.9%	0.090%
5/17/2022	Ensign Peak Advisors Inc	96,469	$7.66M	0.0%	-20.4%	0.044%
5/17/2022	Eqis Capital Management Inc.	5,853	$0.47M	0.0%	-20.2%	0.003%
5/17/2022	Guggenheim Capital LLC	131,716	$10.46M	0.1%	+3.7%	0.059%
5/16/2022	California State Teachers Retirement System	314,150	$24.95M	0.0%	-5.9%	0.142%
5/16/2022	Goldman Sachs Group Inc.	813,460	$64.61M	0.0%	+9.2%	0.367%
5/16/2022	Captrust Financial Advisors	3,362	$0.27M	0.0%	+75.0%	0.002%
5/16/2022	Allstate Corp	13,914	$1.11M	0.0%	+3.6%	0.006%
5/16/2022	Brinker Capital Investments LLC	27,037	$2.15M	0.0%	-11.7%	0.012%
5/16/2022	Wellington Management Group LLP	9,338,192	$741.64M	0.1%	+3.7%	4.216%
5/16/2022	State Street Corp	9,254,772	$735.01M	0.0%	-1.0%	4.178%
5/16/2022	Paradigm Biocapital Advisors LP	234,419	$18.62M	4.9%	N/A	0.106%
5/16/2022	Ethic Inc.	2,532	$0.20M	0.0%	N/A	0.001%
5/16/2022	Echo Street Capital Management LLC	4,212	$0.34M	0.0%	-37.6%	0.002%
5/16/2022	Engineers Gate Manager LP	5,050	$0.40M	0.0%	-67.6%	0.002%
5/16/2022	United Capital Financial Advisers LLC	9,625	$0.76M	0.0%	-3.6%	0.004%
5/16/2022	Quantitative Investment Management LLC	16,510	$1.31M	0.1%	N/A	0.007%
5/16/2022	Cresset Asset Management LLC	2,612	$0.21M	0.0%	-4.9%	0.001%
5/16/2022	Vident Investment Advisory LLC	7,887	$0.63M	0.0%	N/A	0.004%
5/16/2022	Capital Group Private Client Services Inc.	5,576	$0.44M	0.0%	N/A	0.003%
5/16/2022	Invesco Ltd.	1,780,125	$141.38M	0.0%	+0.2%	0.804%
5/16/2022	Achmea Investment Management B.V.	16,184	$1.29M	0.0%	+37.2%	0.007%
5/16/2022	UBS Group AG	2,936,589	$233.22M	0.1%	+204.8%	1.326%
5/16/2022	Hsbc Holdings PLC	369,829	$29.46M	0.0%	+127.4%	0.167%
5/13/2022	Renaissance Technologies LLC	4,697,633	$373.09M	0.4%	+2.3%	2.121%
5/13/2022	Bellevue Group AG	2,847,400	$226.14M	2.6%	-3.7%	1.285%
5/13/2022	Ontario Teachers Pension Plan Board	8,644	$0.69M	0.0%	-23.7%	0.004%
5/13/2022	Northern Trust Corp	1,979,892	$157.24M	0.0%	-1.4%	0.894%
5/13/2022	ING Groep NV	10,333	$0.82M	0.0%	-57.8%	0.005%
5/13/2022	Charles Schwab Investment Management Inc.	1,104,205	$87.70M	0.0%	+4.4%	0.499%
5/13/2022	Frontier Wealth Management LLC	3,800	$0.30M	0.0%	-59.6%	0.002%
5/13/2022	Edgestream Partners L.P.	65,123	$5.17M	0.4%	N/A	0.029%
5/13/2022	Lazard Asset Management LLC	85,634	$6.80M	0.0%	-11.2%	0.039%
5/13/2022	Utah Retirement Systems	32,929	$2.62M	0.0%	-1.8%	0.015%
5/13/2022	Gabelli Funds LLC	16,500	$1.31M	0.0%	+1.2%	0.007%
5/13/2022	Caisse DE Depot ET Placement DU Quebec	83,185	$6.61M	0.0%	+364.3%	0.038%
5/13/2022	Arrowstreet Capital Limited Partnership	801,824	$63.68M	0.1%	+4.9%	0.362%
5/13/2022	Parkwood LLC	16,518	$1.31M	0.2%	-16.3%	0.007%
5/13/2022	DCF Advisers LLC	45,500	$3.61M	1.6%	-35.0%	0.021%
5/13/2022	First Trust Advisors LP	909,762	$72.25M	0.1%	-9.5%	0.411%
5/13/2022	Cibc World Markets Corp	38,704	$3.07M	0.0%	+9.3%	0.017%
5/13/2022	Royal London Asset Management Ltd.	65,121	$5.17M	0.0%	+4.9%	0.029%
5/13/2022	Prudential Financial Inc.	159,624	$12.68M	0.0%	-37.6%	0.072%
5/13/2022	Federated Hermes Inc.	217,331	$17.26M	0.0%	+0.3%	0.098%
5/13/2022	USS Investment Management Ltd	60,297	$4.79M	0.0%	+46.1%	0.027%
5/13/2022	American International Group Inc.	63,794	$5.07M	0.0%	-2.2%	0.029%
5/13/2022	Bridgewater Associates LP	50,810	$4.04M	0.0%	+130.0%	0.023%
5/13/2022	Mackenzie Financial Corp	118,464	$9.41M	0.0%	+129.8%	0.053%
5/13/2022	West Family Investments Inc.	2,767	$0.22M	0.1%	N/A	0.001%
5/13/2022	Covestor Ltd	2,853	$0.23M	0.2%	+153.6%	0.001%
5/13/2022	Parkside Financial Bank & Trust	447	$36K	0.0%	+91.0%	0.000%
5/13/2022	Loomis Sayles & Co. L P	2,207	$0.18M	0.0%	-54.3%	0.001%
5/13/2022	Baird Financial Group Inc.	264,699	$21.03M	0.1%	-3.4%	0.119%
5/13/2022	Candriam Luxembourg S.C.A.	751,759	$59.70M	0.4%	-2.9%	0.339%
5/13/2022	Vanguard Group Inc.	20,886,756	$1.66B	0.0%	-0.3%	9.429%
5/13/2022	National Pension Service	319,382	$25.37M	0.0%	N/A	0.144%
5/13/2022	Sequoia Financial Advisors LLC	4,956	$0.39M	0.0%	-26.7%	0.002%
5/13/2022	Mackay Shields LLC	27,009	$2.15M	0.0%	-3.6%	0.012%
5/13/2022	Cetera Investment Advisers	5,439	$0.43M	0.0%	+46.4%	0.002%
5/13/2022	Prudential PLC	33,481	$2.66M	0.0%	+29.5%	0.015%
5/13/2022	Allianz Asset Management GmbH	637,380	$50.62M	0.0%	+29.3%	0.288%
5/13/2022	Canada Pension Plan Investment Board	21,067	$1.67M	0.0%	-90.8%	0.010%
5/13/2022	Aviva PLC	104,065	$8.27M	0.0%	+29.1%	0.047%
5/13/2022	Sei Investments Co.	76,861	$6.10M	0.0%	+12.7%	0.035%
5/13/2022	Blair William & Co. IL	18,658	$1.48M	0.0%	+23.2%	0.008%
5/13/2022	Vontobel Holding Ltd.	5,286	$0.42M	0.0%	-66.8%	0.002%
5/13/2022	Dimensional Fund Advisors LP	596,022	$47.34M	0.0%	+7.8%	0.269%
5/12/2022	Integral Health Asset Management LLC	18,000	$1.43M	0.4%	-40.0%	0.008%
5/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	28,986	$2.30M	0.0%	-12.0%	0.013%
5/12/2022	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	15,790	$1.25M	0.0%	+71.3%	0.007%
5/12/2022	Yousif Capital Management LLC	28,147	$2.24M	0.0%	-1.4%	0.013%
5/12/2022	Great West Life Assurance Co. Can	168,328	$14.11M	0.0%	-15.4%	0.076%
5/12/2022	Exencial Wealth Advisors LLC	3,740	$0.30M	0.0%	+15.5%	0.002%
5/12/2022	APG Asset Management N.V.	1,083,700	$77.35M	0.1%	-0.7%	0.489%
5/12/2022	BlackRock Inc.	18,093,089	$1.44B	0.0%	-1.3%	8.168%

Data available starting January 2016

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $77.67

$75.36

$77.87

50 Day Range

MA: $74.57

$66.18

$80.72

52 Week Range

Now: $77.67

$61.91

$84.86

Volume

1,319,764 shs

Average Volume

1,592,560 shs

Market Capitalization

$17.20 billion

P/E Ratio

18.49

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of Incyte?: Incyte's top insider shareholders include:
Herve Hoppenot (CEO)
Yao Wenqing (EVP)
Steven H Stein (EVP)
Barry P Flannelly (EVP)
Maria E Pasquale (EVP)
Dashyant Dhanak (EVP)
Bros Advisors Lp Baker (Director)
Herve Hoppenot (President)
Jonathan Elliott Dickinson (EVP)
Michael James Morrissey (EVP)
Paula J Swain (EVP)
Vijay K Iyengar (EVP)
Wendy L Dixon (Director)
Learn More about top insider investors at Incyte.